|
|
||||||||
1 Department of Pediatrics and 2 Department of Genetics, Center for Human Genetics, Case Western Reserve University, Cleveland, Ohio 44106-4948
We have previously
shown that C-type natriuretic peptide (CNP), a guanylate
cyclase agonist, can stimulate cystic fibrosis transmembrane
conductance regulator (CFTR)-mediated chloride secretion in murine
airway epithelial cells via protein kinase (PK) A activation through
the inhibition of cGMP-inhibited phosphodiesterases. In this paper, we
show that CNP is also capable of reducing amiloride-sensitive sodium
absorption in murine airway epithelium through a cGMP-dependent mechanism that is separate from the CFTR regulatory signaling pathway.
Both murine tracheal and nasal tissues exhibit sensitivity to
amiloride-sensitive sodium regulation by exogenously added CNP. CNP
depolarized the nasal transepithelial potential difference by 6.3 ± 0.5 mV, whereas the cGMP-inhibited phosphodiesterase inhibitor
milrinone actually hyperpolarized the nasal transepithelial potential
difference by 2.0 ± 1.2 mV in mice homozygous for a CFTR stop
mutation [CFTR(
/
)]. Inhibition of guanylate
cyclase activity and PKG activity in normal mice resulted in an
increase in amiloride-sensitive sodium absorption, suggesting that
tonic regulation of amiloride-sensitive sodium absorption is in part due to basal cGMP levels and PKG activity.
guanylate cyclase; guanosine 3',5'-cyclic monophosphate
This article has been cited by other articles:
![]() |
J. F. Poschet, G. S. Timmins, J. L. Taylor-Cousar, W. Ornatowski, J. Fazio, E. Perkett, K. R. Wilson, H. D. Yu, H. R. de Jonge, and V. Deretic Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L712 - L719. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Brady, T. J. Kelley, and M. L. Drumm Examining basal chloride transport using the nasal potential difference response in a murine model Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1173 - L1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. HEBESTREIT, U. KERSTING, B. BASLER, R. JESCHKE, and H. HEBESTREIT Exercise Inhibits Epithelial Sodium Channels in Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 443 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Cummings and H. Wang Nitric oxide decreases lung liquid production via guanosine 3',5'-cyclic monophosphate Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L923 - L929. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Elmer, K. G. Brady, M. L. Drumm, and T. J. Kelley Nitric oxide-mediated regulation of transepithelial sodium and chloride transport in murine nasal epithelium Am J Physiol Lung Cell Mol Physiol, March 1, 1999; 276(3): L466 - L473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Lin, R.-C. Lee, P.-C. Yang, F.-M. Ho, and M.-L. Kuo Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells. INVOLVEMENT OF PHOSPHATIDYLINOSITOL 3-KINASE/Akt PATHWAY J. Biol. Chem., December 21, 2001; 276(52): 48997 - 49002. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |